Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point-of-care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Oct 2019  |  Report ID: GMI4408  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 180   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry trends

Helicobacter Pylori Testing Market size was valued at over USD 340 million in 2018 and is estimated to grow at a CAGR of more than 7.5% between 2019 and 2025.

Helicobacter Pylori Testing Market Overview

Get more details on this report - Request Free Sample PDF

Helicobacter pylori (H. pylori) is an aerobic, gram-negative bacteria primarily detected in the stomach. It plays a vital role in sustaining the stomach ecosystem. H. pylori infection is caused when spiral-shaped bacteria attacks oesophagus, small intestine & stomach lining that lead to gastric cancer, peptic ulcers, and chronic gastritis. According to the National Institute of Health, globally about 80% of adults & 10% of children are prone to have H. pylori infection. To detect the infection, different types of test such as breath test, stool antigen test, tissue biopsy, etc. are available in the market. Furthermore, various newer tests are under different development stages. Hence, introduction of new innovative tests will augment the helicobacter pylori testing market growth.

The helicobacter pylori testing market will witness an influx of new and private companies offering innovative and affordable coverage in future. Also, industry players are investing immensely in R&D processes to offer distinguished solutions and gain competitive advantage. Developed countries are implementing non-invasive methodologies in numerous areas of healthcare. In addition, various government organizations are putting efforts to create awareness in public regarding H. Pylori infection will propel the market expansion during the forecast timeframe.

The recent outbreak of COVID-19 has had a significant impact on the helicobacter pylori testing market due to abdominal pain and diarrhea actively interrelated with the presence of H. pylori in COVID-19 patients. According to the recently published article, H. pylori colonization affects immune homeostasis in severe COVID-19 conditions. Additionally, coronavirus binds angiotensin-converting enzyme-2 (ACE-2) receptors to enter the cell and H. pylori are identified to raise the expression of ACE-2 receptors in the gastrointestinal tract. Clinical studies have demonstrated that the incidence of diarrhea is between 2% to 50% with an average of 10% correlated with COVID-19 infection. These bacteria play a role in hindering the hyper inflammation characteristic of critical COVID-19 patients.

Human leukocyte antigen is known to be important for H. pylori mediated gastric cancer. Thus, they play a key role in causing gastrointestinal symptoms related to COVID-19.  In research studies, people infected with H. pylori were found to exhibit more critical digestive system discomfort if they contract coronavirus. For instance, physicians strongly recommend that patients with helicobacter are required to get immediate treatment so that they would face fewer digestive issues in case they contract the coronavirus. Thus, owing to the strong correlation between H. pylori and COVID-19, the surging demand for helicobacter pylori testing is expected to impact the industry revenue positively.

Gastric ulcers to boom the helicobacter pylori testing market value

In forthcoming years, the market for H. pylori testing will observe a rapid expansion around the globe. The foremost factors that will contribute significantly to development are, increase in geriatric population & growing cases of patients suffering from numerous infectious diseases and gastritis. An approximate one of six entities infected with H. pylori are likely to develop peptic ulcer disorder. Affected individuals suffer long asymptomatic conditions. Among them, almost 70% suffer from minimal symptoms such as burping, vomiting, bloating, nausea, stomach discomfort as occasional, whereas, major symptoms include abdominal & intestinal pain, peptic ulcer, bad breath etc.

Nonetheless, as more regions of globe get access to uncontaminated water & sanitation, the frequency of infection will decline, ultimately hampering the growth of the testing market. Furthermore, demand for serological tests is declining owing to less sensitivity & inaccuracy of test results leading to decline in the segment growth in global market. Lack of awareness regarding H. pylori infection and high cost of biopsy associated diagnostics are likely to obstruct the industry growth during the forecast period.

Urea breath test to attain new altitudes in the market

Helicobacter Pylori Testing Market Size

Get more details on this report - Request Free Sample PDF

Non-Invasive segment in the helicobacter pylori testing market is poised to register growth of 7.8% through 2025 led by the soaring prevalence of infections occurred and awareness against the same. Escalating rate of adoption of enhanced non-invasive technologies coupled with rising number of firms offering innovative testing kits will strengthen the industry expansion. For instance, urea breath test is gaining popularity for its rapid diagnostics capability, safety and high sensitivity for detecting H. pylori infection in children. Growing number of public & private investments and surge in research grants should fuel the market progression.

Point-of-care (POC) continue to dominate the overall helicobacter pylori testing market demand

POC test accounted for around 120 million in 2018. The POC testing is less expensive and gives accurate results in short time span. The companies operating in the market are focusing on development of advanced diagnostics kits. The new product development for H. pylori testing is slated to propel the industry progression in coming years. Advent of home diagnostic kits is providing the opportunity for the growth of market. 

Hospitals will aid in boosting evolution of the helicobacter pylori testing market revenue

Hospital segment captured more than 30% of the market share in 2018. The elderly population base has a high preference towards hospitals due to convenience offered by them to the patients. Moreover, large number of patient pool, and high acceptance of new tests and instruments for diagnosis of H. pylori is expected to foster the growth of hospital end-use segment.

High number of companies in the U.S. to impel the market growth

Asia Pacific Helicobacter Pylori Testing Market

Get more details on this report - Request Free Sample PDF

Asia Pacific helicobacter pylori testing market is projected to showcase over 8.5% growth rate by 2025 on account of the rising occurrence of gastric cancer in China, Japan and India. For instance, according to the Chinese University of Hong Kong (CUHK), in 2017, over 50% of the Asian populace were affected by H. pylori, impacting to the overall progress of the market. The market in the region is also set to expand credited to intensifying development in biotechnology industry. In addition, the development in testing sectors across these countries are estimated to fuel the growth of market during forecast period.

The U.S. helicobacter pylori testing market is anticipated to register significant growth during the forecast timeline. Rising consciousness about testing options, rapid technological advancements in the field of H. pylori will benefit the overall market expansion in the country. Moreover, the well-established healthcare infrastructure, discovery of technologies, higher diagnosis rate and increasing geriatric population will contribute towards the revenue growth. Government organizations such as the Centers for Medicare & Medicaid Services (CMS), U.S. FDA and the Center for Disease Control (CDC) regulates & ensures quality laboratory testing. Presence of such institutions contribute positively to this region’s development. In total, CLIA covers approximately 260,000 laboratory entities. Thus, constant innovation, high-end technology, acquisitions and novel product launches in the U.S. has positively impacted the industry demand.

Meridian Biosciences is one of the prominent players in stool antigen testing for the helicobacter pylori testing market

Meridian Biosciences is one of the leaders in biotechnology, in-vitro diagnostics and tissue-based cancer diagnostics. The company is operating in the industry since 1896 and undertakes various strategic initiatives including new product launch to strengthen its business. Other key participants operating in the global market include Abbott, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Quidel Corporation and Thermo Fisher. These leaders adopt various policies such as acquisitions, mergers, and geographic expansion to expand business.

Recent industry developments:

  • In Feb 2019, Exalenz Bioscience Ltd. announced that the China Food and Drug Administration has permitted Exalenz to initiate marketing and selling its BreathID Hp Lab System for detection of H. pylori bacteria
  • In October 2018, DiaSorin and Meridian Bioscience, Inc. strategically collaborated to sell DiaSorin’s FDA-cleared Helicobacter pylori stool antigen test to identify H. pylori for use on its automated LIAISON platform under the Meridian brand name worldwide.

The helicobacter pylori testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

Market, By Test Type

  • Invasive 
    • Histology
    • Rapid Urease Test           
    • HP Culture   
  • Non-invasive 
    • Serologic Test
    • Urea Breath Test
    • Stool Antigen Test

Market, By Method

  • Point of care (POC) test
  • Laboratory based test

Market, By End-use

  • Clinics
  • Hospitals
  • Diagnostic laboratories
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Poland
    • Spain
    • Romania
    • Russia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Nigeria
    • Turkey
    • Others

Frequently Asked Questions (FAQ) :

The market size of helicobacter pylori testing surpassed USD 340 million in 2018.
The industry share of helicobacter pylori testing is set to achieve over 7.5% CAGR up to 2025.
Helicobacter pylori is an aerobic, gram-negative bacteria primarily detected in the stomach. It plays a vital role in sustaining the stomach ecosystem.
The point-of-care (POC) segment of the helicobacter pylori testing industry dominates the business with USD 120 million revenue share in 2018.
Rise in prevalence of gastric ulcer and high adoption of non-invasive diagnostics will be key driving factors for the growth of helicobacter pylori testing business worldwide.

Premium Report Details

  • Published Date: Oct 2019
  • Pages: 180
  • Tables: 162
  • Charts / Figures: 9
  • Companies covered: 11
  • Countries covered: 23

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X